+ 49 (0) 2204 2918806

Sirtris Pharmaceuticals, Inc. – Product Pipeline Review – 2013

SKU:GMDHC03704CDB / 330006
Publication Date:27.05.2013
Language version:English
Report Type:Report
Lieferzeit:2-3 Tage
Nr of pages:32 pages
Rating:Für diese Studie liegt keine Bewertung vor.
$1,500.00   *
* Click here to switch the currency you want to pay in.
More about this report
Table of Contents
Other relevant reports
Our guarantee

Content of the report


Global Market Direct’s pharmaceuticals report, “Sirtris Pharmaceuticals, Inc. - Product Pipeline Review - 2013” provides data on the Sirtris Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sirtris Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Sirtris Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.


- Sirtris Pharmaceuticals, Inc. - Brief Sirtris Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sirtris Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sirtris Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sirtris Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.


Reasons to buy

- Evaluate Sirtris Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sirtris Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sirtris Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sirtris Pharmaceuticals, Inc
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sirtris Pharmaceuticals, Inc. and identify potential opportunities in those areas.